To assess whether the cardiovascular effects induced by early blockade
of bradykinin B-2-receptors with Hoe 140 (D-Arg[Hyp(3),Thi(5),D-Tic(7
),Oic(8)]-bradykinin) are influenced by sex, Wistar rats of both sexes
received the antagonist (300 nmol/d per kilogram body wt) or vehicle
from 2 days to 7 weeks of age by subcutaneous injection and then by in
traperitoneal infusion. Compared with control rats, Hoe 140-treated fe
male rats showed higher systolic blood pressure levels at 7 and 9 week
s of age (125+/-2 versus 111+/-2 mmHg and 132+/-3 versus 116+/-2 mm Hg
, respectively, P<.05), whereas in male rats a difference was found at
7 weeks (122+/-4 versus 108+/-4 mm Hg, P<.05) but not at 9 weeks. At
this stage, the mean blood pressure of Hoe 140-treated rats was higher
than that of control animals, and this difference was more pronounced
at 12 weeks in female rats (121+/-2 versus 100+/-3 mm Hg in control a
nimals, P<.01) compared with males (116+/-3 versus 104+/-2 mm Hg in co
ntrol rats, P<.05). After the first week of life, body weight gain was
greater in Hoe 140-treated female rats than in control rats, whereas
a group-difference was detected in male rats only after weaning. In Ho
e 140-treated female rats, heart weight was already increased at 9 wee
ks (330+/-6 versus 305+/-5 mg/100 g body wt in control rats, P<.05), w
hereas it was necessary to prolong Hoe 140 administration in male rats
to develop heart hypertrophy (300+/-4 versus 275+/-4 mg/100 g body wt
in control rats at 12 weeks, P<.05). Tissue kallikrein mRNA levels we
re higher in the kidney of adult female rats, whereas no sex differenc
e was detected in the heart. The finding of a sexual dimorphism in the
cardiovascular response to early blockade of bradykinin receptor sugg
ests that endogenous kinins play a role in the regulation of cardiovas
cular function in both sexes, but they may be functionally more import
ant in the female rat.